Mosaic (NYSE: MOS) officer to sell $509K in stock in 2026 plan

Mosaic Biosciences, a unit of The Mosaic Company (MOS), launched Renuvis Enzara, an enzyme-based treatment for crop residue. MOS reported a Q2 net loss of $273M, reversing from a $411M profit in 2025. The company cut its 2026 capex outlook to $1.2B and sold a potash mine. Phosphate segment losses widened, while Potash remained stable. Shares trade at a forward P/E of 15.92.

Rainbow Rare Earths (RBW) and Mosaic (MOS) started a Pre-Feasibility Study for the Uberaba rare earths project in Brazil. SRK Consulting will prepare a JORC-compliant Mineral Resource Estimate. Mosaic will ship 6 tonnes of phosphogypsum for testing. The study aims to build a processing plant for 2.7M tonnes/year of phosphogypsum waste, producing rare earth oxides. An Economic Assessment in March showed a post-tax NPV10 of $916M, IRR of 45%, and average EBITDA of $217M/year over 30 years.

The U.S. Department of Justice is investigating leading fertilizer producers, including Nutrien, Mosaic, CF Industries, Koch, and Yara, for potential antitrust violations. Iowa Corn Growers Association President Mark Mueller cites industry consolidation and high prices as concerns. Farmers argue that fewer suppliers have not led to promised cost savings. The investigation is in early stages, with no accusations made. Farmers seek greater transparency in pricing.

Mosaic (NYSE: MOS) set the pricing terms for cash tender offers to repurchase certain outstanding debt. It will buy 4.050% 2027 notes, 7.30% 2028 debentures, 5.375% 2028 notes, and 4.350% 2029 notes, up to a $1.4 billion tender cap, with a $150 million series cap for 2029 notes. Expiration is Aug. 14, 2026, settlement expected Aug. 18.

Mosaic (NYSE:MOS) said Q2 U.S. phosphate application was nearly 15% below normal and could drop another 20% in 2027. In Brazil, it expects phosphate nutrient application to fall about 30% in 2024 after normal levels in 2023, citing yield pressure. Mosaic guided Q3 sulfur costs $700-$710/ton, ammonia $610-$620, DAP FOB $820-$840, and Q3 phosphate sales 1.1-1.4M tons.

S&P Global Ratings downgraded Mosaic Co.’s outlook to negative from stable while keeping its BBB issuer credit rating. It expects funds from operations to debt below 20% in 2026. It projects adjusted EBITDA around $1.6B in 2026 vs $2.6B in 2025, citing high sulfur and ammonia costs, weaker phosphate margins, and negative discretionary cash flow of $400M to $500M.